BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2813082)

  • 1. [Use of fluorodeoxyglucose PET in the diagnosis of central nervous system lupus erythematosus and a comparison with CT and MRI].
    Stoppe G; Wildhagen K; Meyer GJ; Schober O
    Nuklearmedizin; 1989 Oct; 28(5):187-92. PubMed ID: 2813082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography and magnetic resonance imaging for cerebral involvement in patients with systemic lupus erythematosus.
    Sailer M; Burchert W; Ehrenheim C; Smid HG; Haas J; Wildhagen K; Wurster U; Deicher H
    J Neurol; 1997 Mar; 244(3):186-93. PubMed ID: 9050960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET.
    Weiner SM; Otte A; Schumacher M; Klein R; Gutfleisch J; Brink I; Otto P; Nitzsche EU; Moser E; Peter HH
    Ann Rheum Dis; 2000 May; 59(5):377-85. PubMed ID: 10784521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of FDG-PET, HMPAO-SPET and MRI in the detection of brain involvement in patients with systemic lupus erythematosus.
    Kao CH; Lan JL; ChangLai SP; Liao KK; Yen RF; Chieng PU
    Eur J Nucl Med; 1999 Feb; 26(2):129-34. PubMed ID: 9933346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography study.
    Otte A; Weiner SM; Peter HH; Mueller-Brand J; Goetze M; Moser E; Gutfleisch J; Hoegerle S; Juengling FD; Nitzsche EU
    Eur J Nucl Med; 1997 Jul; 24(7):787-91. PubMed ID: 9211766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography in neuropsychiatric lupus erythematosus.
    Stoppe G; Wildhagen K; Seidel JW; Meyer GJ; Schober O; Heintz P; Künkel H; Deicher H; Hundeshagen H
    Neurology; 1990 Feb; 40(2):304-8. PubMed ID: 2132733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral involvement in systemic lupus erythematosus (SLE): comparison of positron emission tomography (PET) with other imaging methods.
    Meyer GJ; Schober O; Stoppe G; Wildhagen K; Seidel JW; Hundeshagen H
    Psychiatry Res; 1989 Sep; 29(3):367-8. PubMed ID: 2608795
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cerebral positron emission tomographic study in systemic lupus erythematosus].
    Csépány T; Gulyás B; Trón L; Szakáll S; Kiss E; Kollár J; Sikula J; Szegedi G; Csiba L
    Orv Hetil; 1997 Aug; 138(31):1947-52. PubMed ID: 9280887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET/CT imaging in systemic lupus erythematosus.
    Curiel R; Akin EA; Beaulieu G; DePalma L; Hashefi M
    Ann N Y Acad Sci; 2011 Jun; 1228():71-80. PubMed ID: 21718325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral involvement in systemic lupus erythematosus.
    Volkow ND; Warner N; McIntyre R; Valentine A; Kulkarni M; Mullani N; Gould L
    Am J Physiol Imaging; 1988; 3(2):91-8. PubMed ID: 3260788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychiatric systemic lupus erythematosus: correlation of brain MR imaging, CT, and SPECT.
    Abreu MR; Jakosky A; Folgerini M; Brenol JC; Xavier RM; Kapczinsky F
    Clin Imaging; 2005; 29(3):215-21. PubMed ID: 15855069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of systemic lupus erythematosus (SLE) involving the central nervous system by magnetic resonance imaging (MRI)].
    Suzuki K; Hara M; Nakajima S; Hirose T; Kitani A; Norioka K; Harigai M; Kawakami M; Tabata H; Kawagoe M
    Ryumachi; 1989 Apr; 29(2):88-96. PubMed ID: 2772757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of brain (18)F-fluorodeoxyglucose positron emission tomography in neuropsychiatric lupus patients with normal brain magnetic resonance imaging findings.
    Lee SW; Park MC; Lee SK; Park YB
    Lupus; 2012 Dec; 21(14):1531-7. PubMed ID: 22941565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings.
    Kao CH; Ho YJ; Lan JL; Changlai SP; Liao KK; Chieng PU
    Arthritis Rheum; 1999 Jan; 42(1):61-8. PubMed ID: 9920015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of the use of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography to assess the distribution of activated lymphocytes in patients with systemic lupus erythematosus.
    Nowak M; Carrasquillo JA; Yarboro CH; Bacharach SL; Whatley M; Valencia X; Takada K; Brust DG; Illei GG
    Arthritis Rheum; 2004 Apr; 50(4):1233-8. PubMed ID: 15077306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolution of neuropsychological and FDG-PET abnormalities in a patient with neuropsychiatric systemic lupus erythematosus.
    Adeli A; Drubach DA; Machulda MM
    Cogn Behav Neurol; 2013 Sep; 26(3):161-6. PubMed ID: 24077576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuropsychiatric involvement in systemic lupus erythematosus. Part 2: diagnostic and therapy].
    Weiner SM; Otte A; Uhl M; Brink I; Schumacher M; Peter HH
    Med Klin (Munich); 2003 Feb; 98(2):79-90. PubMed ID: 12601532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of F-18 FDG PET-CT in neuropsychiatric systemic lupus erythematosus.
    Berndorfler BD; Warwick JM; Doruyter AGG
    Compr Psychiatry; 2024 Jul; 132():152480. PubMed ID: 38555700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.